| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net loss | -293,534 | -216,084 | -118,016 | -1,995,965 |
| Depreciation and amortization | 203,145 | 133,669 | 65,431 | 387,545 |
| Amortization of deferred financing costs and debt discount | 19,364 | 12,502 | 5,796 | 12,266 |
| Straight-line rent revenue and other | - | - | - | 127,326 |
| Straight-line rent revenue from operating and finance leases | 120,674 | 82,758 | 41,601 | - |
| Stock / unit-based compensation expense | 30,864 | 18,522 | 17,665 | 30,581 |
| Gain on sale of real estate | 4,156 | 13,271 | 8,059 | 475,196 |
| Real estate and other impairment charges, net | 167,132 | 81,479 | 79,581 | 1,438,429 |
| Equity interest real estate impairment | 0 | 0 | - | 410,790 |
| Straight-line rent and other write-off | - | - | - | 2,846 |
| Debt refinancing and unutilized financing costs | 3,629 | 3,615 | 3,796 | 3,677 |
| Tax rate changes and other | -10,970 | 1,121 | 1,102 | 4,596 |
| Non-cash fair value adjustments | 123,370 | 135,436 | 26,609 | 511,472 |
| Non-cash revenue from debt and equity securities received | - | - | - | 0 |
| Other adjustments | 9,724 | 5,315 | -2,473 | -12,406 |
| Interest and rent receivables | -8,305 | -4,565 | -6,626 | -4,147 |
| Other assets | -6,756 | 3,301 | 1,792 | 18,884 |
| Accounts payable and accrued expenses | -45,719 | -11,878 | -35,400 | -20,869 |
| Deferred revenue | -7,085 | -6,171 | -3,827 | -11,719 |
| Net cash provided by operating activities | 70,703 | 52,131 | 384 | 168,796 |
| Cash paid for acquisitions and other related investments | 110,089 | 102,329 | 39,314 | 105,618 |
| Net proceeds from sale of real estate | 96,961 | 47,918 | 19,837 | 1,761,661 |
| Proceeds received from sale and repayment of loans receivable | 10,049 | 3,000 | 0 | 214,416 |
| Investment in loans receivable | 158,974 | 52,435 | 21,800 | 392,241 |
| Construction in progress and other | 60,747 | 40,623 | 26,053 | 63,535 |
| Proceeds from sale and return of equity investments | 0 | 0 | 0 | 11,656 |
| Capital additions and other investments, net | 34,069 | 17,265 | 22,086 | 199,735 |
| Net cash (used for) provided by investing activities | -256,869 | -161,734 | -89,416 | 1,226,604 |
| Proceeds from term debt | 2,512,970 | 2,512,970 | 2,512,970 | 804,188 |
| Payments of term debt | 2,252,731 | 2,252,731 | 2,252,731 | 662,968 |
| Revolving credit facility, net | 171,530 | 156,530 | 258,433 | -1,119,312 |
| Dividends / distribution paid | 144,840 | 96,548 | 48,164 | 272,909 |
| Lease deposits and other obligations to tenants | -2,475 | -1,970 | -3,243 | 726 |
| Offering costs | 644 | 101 | - | - |
| Stock / unit vesting - satisfaction of tax withholdings | 1,478 | 745 | 289 | 3,252 |
| Other financing activities, payment of debt refinancing, and deferred financing costs | - | - | - | -124,595 |
| Payment of debt refinancing and deferred financing costs and other financing activities | 50,218 | 49,822 | 47,142 | - |
| Net cash provided by (used for) financing activities | 237,064 | 271,523 | 426,320 | -1,379,574 |
| Increase in cash, cash equivalents, and restricted cash for period | 50,898 | 161,920 | 337,288 | 15,826 |
| Effect of exchange rate changes on cash | 13,562 | 15,815 | 4,024 | 7,969 |
| Cash and cash equivalents at beginning of period | 335,173 | 335,173 | 335,173 | 255,952 |
| Cash and cash equivalents at end of period | 399,633 | 512,908 | 676,485 | 279,747 |
MEDICAL PROPERTIES TRUST INC (MPW)
MEDICAL PROPERTIES TRUST INC (MPW)